Samuel Lederman

2.4k citations

18 papers · 1.3k indexed · 2 hit papers · h-index 11

Impact in

Orthopedics and Sports Medicine top 1%
- Bone health and osteoporosis research
- Bone and Joint Diseases
Oncology top 5%
- Bone health and treatments

Papers in ⓘ

Reproductive Medicine 4
- Hypothalamic control of reproductive hormones 3
Endocrinology, Diabetes and Metabolism 7
- Menopause: Health Impacts and Treatments 6

Co-authors: Alfred H. Moffett (3 shared papers)Michael R. McClung (2 shared papers)Charles H. Chesnut (2 shared papers)Pirow Bekker (2 shared papers)Paul D. Miller (2 shared papers)Donna Holloway (2 shared papers)Grattan C. Woodson (2 shared papers)Mark Peterson (2 shared papers)
Journals: Obstetrics and Gynecology (2 papers)Menopause The Journal of The North American Menopause Society (2 papers)Journal of Cardiovascular Pharmacology (2 papers)Clinical Infectious Diseases (1 paper)Canadian Journal of Physiology and Pharmacology (1 paper)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Samuel Lederman

17 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study 2023 · 122 citations

Peers

Countries citing papers authored by Samuel Lederman

Since Specialization

Citations

This map shows the geographic impact of Samuel Lederman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Lederman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Lederman more than expected).

Fields of papers citing papers by Samuel Lederman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Lederman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Lederman. The network helps show where Samuel Lederman may publish in the future.

Co-authors

The 25 scholars most cited alongside Samuel Lederman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Samuel Lederman Line = papers co-authored together Samuel Lederman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Denosumab in Postmenopausal Women with Low Bone Mineral Density New England Journal of Medicine ·Michael R. McClung, E. Michael Lewiecki, Stanley Cohen, Michael A. Bolognese, Grattan C. Woodson, Alfred H. Moffett, Munro Peacock, Paul D. Miller, Samuel Lederman, Charles H. Chesnut, Douglas Lain, Alan Kivitz, Donna Holloway, Charlie Zhang, Mark Peterson, Pirow Bekker Hit paper breakdown →	2006	886
2	Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study The Lancet ·Samuel Lederman, Faith D Ottery, Antonio Cano, Nanette Santoro, Marla Shapiro, Petra Stute, Rebecca C. Thurston, Marci English, Catherine Franklin, Misun Lee, Genevieve Neal-Perry Hit paper breakdown →	2023	122
3	A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause Menopause The Journal of The North American Menopause Society ·Graeme L. Fraser, Samuel Lederman, Arthur Waldbaum, Robin Kroll, Nanette Santoro, Misun Lee, Laurence Skillern, Steven Ramael	2020	75
4	Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303) Clinical Infectious Diseases ·Jane R. Schwebke, Ryan Sobel, Janet Gersten, Steven A. Sussman, Samuel Lederman, Mark Jacobs, B. Todd Chappell, David Weinstein, Alfred H. Moffett, Nkechi Azie, David Angulo, Itzel A Harriott, Katyna Borroto–Esoda, Mahmoud A. Ghannoum, Paul Nyirjesy, Jack D. Sobel	2021	62
5	Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause Obstetrics and Gynecology ·Genevieve Neal-Perry, Antonio Cano, Samuel Lederman, Rossella E. Nappi, Nanette Santoro, Wendy Wolfman, Marci English, Catherine Franklin, Udaya Valluri, Faith D Ottery	2023	59
6	Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA) Menopause The Journal of The North American Menopause Society ·Nanette Santoro, Arthur Waldbaum, Samuel Lederman, Robin Kroll, Graeme L. Fraser, Christopher Lademacher, Laurence Skillern, James Young, Steven Ramael	2020	44
7	Effects of Flecainide on Occlusion and Reperfusion Arrhythmias in Dogs Journal of Cardiovascular Pharmacology ·Samuel Lederman, Thomas L. Wenger, Eric D. Bolster, Harold C. Strauss	1989	17
8	Denosumab in Postmenopausal Women With Low Bone Mineral Density Obstetrical & Gynecological Survey ·Michael R. McClung, E. Michael Lewiecki, Stanley Cohen, Michael A. Bolognese, Grattan C. Woodson, Alfred H. Moffett, Munro Peacock, Paul D. Miller, Samuel Lederman, Charles H. Chesnut, Douglas Lain, Alan Kivitz, Donna Holloway, Charlie Zhang, Mark Peterson, Pirow Bekker	2006	16
9	Effects of Flecainide on Occlusion and Reperfusion Arrhythmias in Dogs Journal of Cardiovascular Pharmacology ·Samuel Lederman, Thomas L. Wenger, Eric D. Bolster, Harold C. Strauss	1989	15
10	A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium. Circulation ·T. Wenger, Samuel Lederman, C F Starmer, Travis Brown, Harold C. Strauss	1984	14
11	Effects of different paced heart rates on canine coronary occlusion and reperfusion arrhythmias American Heart Journal ·Samuel Lederman, Thomas L. Wenger, Frank E. Harrell, Harold C. Strauss	1987	10
12	A real-world comparison of the clinical and economic utility of OVA1 and CA125 in assessing ovarian tumor malignancy risk Journal of Comparative Effectiveness Research ·Gerard Reilly, David A. Gregory, Dennis J. Scotti, Samuel Lederman, Wade A Neiman, Steven A. Sussman, L.M. Bean, Mercedes M. Ekono	2023	8
13	Phase 3 Study of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause [A132] Obstetrics and Gynecology ·Samuel Lederman, Marla Shapiro, Petra Stute, Misun Lee, Xuegong Wang, Genevieve Neal-Perry	2022	5
14	Ventricular fibrillation following canine coronary artery reperfusion: different outcomes with pentobarbital and α-chloralose Canadian Journal of Physiology and Pharmacology ·Thomas L. Wenger, Frank E. Harrell, Kathleen K. Brown, Samuel Lederman, Harold C. Strauss	1984	5
15	OR33-6 The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study Journal of the Endocrine Society ·Graeme L. Fraser, Samuel Lederman, Arthur Waldbaum, Misun Lee, Laurence Skillern, Steven Ramael	2019	3
16	Nonreactive contraction stress test: clinical significance. PubMed ·H. F. Grundy, Freeman Rk, Samuel Lederman, Wendy Dorchester	1984	2
17	The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: a randomized, placebo-controlled, double-blind, dose-ranging study Maturitas ·Graeme L. Fraser, Samuel Lederman, Arthur Waldbaum, Misun Lee, Laurence Skillern, Steven Ramael	2019	2
18	Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis Journal of Women s Health ·Samuel Lederman, Ryan Sobel, Jack D. Sobel, Stacey Curelop, Stephen Brand	2025	0

About Samuel Lederman

Samuel Lederman is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism, Microbiology, Pathology and Forensic Medicine and Genetics, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (7 papers), Menopause: Health Impacts and Treatments (6 papers), Cardiac electrophysiology and arrhythmias (5 papers), Cardiac Imaging and Diagnostics (4 papers), Cardiac Ischemia and Reperfusion (4 papers), Hypothalamic control of reproductive hormones (3 papers), Bone health and osteoporosis research (2 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (546 citations), Oncology (681 citations), Endocrinology, Diabetes and Metabolism (288 citations), Pathology and Forensic Medicine (198 citations) and Genetics (297 citations). Samuel Lederman has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Alfred H. Moffett, Michael R. McClung, Charles H. Chesnut, Pirow Bekker, Paul D. Miller, Donna Holloway, Grattan C. Woodson, Mark Peterson, Stanley Cohen and Michael A. Bolognese. Their work appears in journals such as Obstetrics and Gynecology, Menopause The Journal of The North American Menopause Society, Journal of Cardiovascular Pharmacology, Clinical Infectious Diseases and Canadian Journal of Physiology and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact